Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Thrombocytopenia
•
Hematology
•
Benign Hematology
•
ITP
•
Hospital Medicine
How would you manage ITP with platelet less than 5K in a septic patient with renal failure?
Related Questions
How would you manage ITP in patients who develop cirrhosis and hemorrhage?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
How do you decide when to use andexanet (ANDEXXA) for intracranial hemorrhage associated with factor Xa inhibitors?
How do you manage patients with embolic stroke of an undetermined source and a papillary fibroelastoma found on an echocardiogram?
How do you choose between therapies for newly diagnosed ITP that is refractory to steroids and IVIG?
Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?
How would you manage anticoagulation in a patient with acute MI or PE with prolonged aPTT due to congenital factor XII deficiency?
How do you manage DIC associated with an aortic aneurysm while awaiting surgical repair?
Would you consider a positive DAT and indirect Coombs test, persistent and consistent with IgG warm antibody, clinically significant in absence of hemolysis?
How quickly do you expect iron stores to decrease after starting iron chelators?